Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer. John L. Marshall, MD: Every patient with colon cancer and every physician treating colon ...
One in every three people is expected to have cancer in their lifetime, making it a major health concern for mankind. A crucial indicator of the outcome of cancer is its tumor microsatellite ...
An overview of data presented at ESMO GI 2023 on combined botensilimab and balstilimab therapy in heavily pretreated patients with microsatellite stable metastatic colorectal cancer. John L. Marshall, ...
Predictive biomarkers remain a key foundation of personalized medicine, enabling the identification of patients most likely ...
Risk factors for early-onset colorectal cancer in the United States: An epidemiologic investigation. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes Microsatellite instability (MSI) and/or mismatch repair deficiency (MMR-D) ...
In a recent study published in eClinicalMedicine, researchers assess the use of fecal microbiota transplantation to enhance the efficacy of anti-programmed cell death protein 1 (PD-1) therapy for ...
One in every three people is expected to have cancer in their lifetime, making it a major health concern for mankind. A crucial indicator of the outcome of cancer is its tumor microsatellite ...
One in every three people is expected to have cancer in their lifetime, making it a major health concern for mankind. A crucial indicator of the outcome of cancer is its tumor microsatellite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results